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Objective: To compare delayed gadolinium-enhanced magnetic resonance imaging (MRI) of cartilage
(dGEMRIC) and delayed quantitative computed tomography (CT) arthrography (dQCTA) to each other,
and their association to arthroscopy. Additionally, the relationship between dGEMRIC with intravenous
(dGEMRICIV) and intra-articular contrast agent administration (dGEMRICIA) was determined.
Design: Eleven patients with knee pain were scanned at 3 T MRI and 64-slice CT before arthroscopy.
dQCTA was performed at 5 and 45 min after intra-articular injection of ioxaglate. Both dGEMRICIV and
dGEMRICIA were performed at 90 min after gadopentetate injection. dGEMRIC indices and change in
relaxation rates (DR1) were separately calculated for dGEMRICIV and dGEMRICIA. dGEMRIC and dQCTA
parameters were calculated for predetermined sites at the knee joint that were International Cartilage
Repair Society (ICRS) graded in arthroscopy.
Results: dQCTA normalized with the contrast agent concentration in synovial ﬂuid (SF) and dGEMRICIV
correlated signiﬁcantly, whereas dGEMRICIA correlated with the normalized dQCTA only when dGEM-
RICIA was also normalized with the contrast agent concentration in SF. Correlation was strongest between
normalized dQCTA at 45 min and DR1,IV (rs ¼ 0.72 [95% CI 0.56e0.83], n ¼ 49, P < 0.01) and DR1,IA
normalized with DR1 in SF (rs ¼ 0.70 [0.53e0.82], n ¼ 52, P < 0.01). Neither dGEMRIC nor dQCTA
correlated with arthroscopic grading. dGEMRICIV and non-normalized dGEMRICIA were not related
while DR1,IV correlated with normalized DR1,IA (rs ¼ 0.52 [0.28e0.70], n ¼ 50, P < 0.01).
Conclusions: This study suggests that dQCTA is in best agreement with dGEMRICIV at 45 min after CT
contrast agent injection. dQCTA and dGEMRIC were not related to arthroscopy, probably because the
remaining cartilage is analysed in dGEMRIC and dQCTA, whereas in arthroscopy the absence of cartilage
deﬁnes the grading. The ﬁndings indicate the importance to take into account the contrast agent con-
centration in SF in dQCTA and dGEMRICIA.
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In osteoarthritis (OA) articular cartilage is progressively degen-
erated. One of the earliest signs of cartilage degeneration is loss of
glycosaminoglycan (GAG) side chains of proteoglycans1,2, partic-
ularly at the superﬁcial layer. Other early degenerative changes in
cartilage include the deterioration of the collagen network and an
increase in water content1,3. There are several factors predisposing
to OA, including age, obesity, joint injuries, and genetics2,4. Further,ublished by Elsevier Ltd. All rights reserved.
Table I
Description of the patients and their preliminary diagnosis according to interna-
tional classiﬁcation of diseases (ICD)-10 codes
Patient Gender Age
(years)
Height
(cm)
Weight
(kg)
Body mass index
(BMI) (kg/m2)
Preliminary
diagnosis
(ICD-10)
1 Male 66 170 71 24.6 M23.2
2 Male 59 176 101 32.6 M23.2
3 Female 55 165 75 27.5 M23.2
4 Female 63 167 73 26.2 M23.2
5 Female 61 167 70 25.1 S83.2
6 Female 40 163 73 27.5 M17.1
7 Female 50 168 90 31.9 M23.2
8 Female 68 152 67 29.0 S83.2
9 Female 55 170 98 33.9 M23.2
10 Female 58 164 55 20.4 M23.2
M17.1 ¼ other primary arthrosis of the knee.
M23.2 ¼ derangement of meniscus due to old tear or injury.
S83.2 ¼ current tear of meniscus.
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opment of OA2,5. There are different treatment options for focal
cartilage lesions6e8 and thus, early and accurate diagnosis of the
cartilage lesions and degenerative changes are important.
Clinical diagnosis of OA is based on the physical examination
and observation of changes on plain radiographs, occasionally fol-
lowed by magnetic resonance imaging (MRI) or arthroscopy.
Unfortunately, current clinical imaging methods are not sensitive
enough to detect cartilage lesions and early OA changes in cartilage.
Arthroscopy is still considered as the gold standard for the evalu-
ation of cartilage lesions, although it is based on subjective visu-
alization and palpation, hence, it includes large inter-observer and
moderate intra-observer variability9e11.
When aiming at earlier diagnosis of the lesions and early OA
changes in cartilage, noninvasive determination of structural and
compositional changes of cartilage tissue is an advantage. One
approach to probe the composition of articular cartilage is to use
negatively charged contrast agent to enhance MR or computed
tomography (CT) imaging. These methods are based on assumption
that negatively charged contrast agent distributes into cartilage in
an inverse relation to the ﬁxed charge density in cartilage asso-
ciated with GAG content of the cartilage12,13. Therefore, higher
concentration of anionic contrast agent diffuses into degraded
cartilage than into intact cartilage. Diffusion and distribution of
contrast agent are, however, inﬂuenced also by other factors in
cartilage, e.g., collagen and water content14e17.
With regard to MRI, a technique called delayed gadolinium-
enhanced MRI of cartilage (dGEMRIC) is based on the afore-
mentioned properties and it has been proposed for quantitative
estimation of the GAG concentration in cartilage12,13,18. The
dGEMRIC method has been applied both in vitro18e20 and
in vivo13,21,22. While the speciﬁcity of dGEMRIC to GAG has been
recently questioned14,17,23, it is reported to sensitively detect
degenerative changes in cartilage21.
In the dGEMRIC method, the contrast agent (gadopentetate,
charge 2) can be administered either intravenously (dGEMRICIV)
or intra-articularly (dGEMRICIA). Intravenously injected contrast
agent may enter the cartilage both through the cartilage surface
and from the subchondral bone whereas intra-articularly injected
contrast agent can diffuse only through the surface13. Although
diffusion of the contrast agent from the subchondral bone was slow
or negligible in recent in vitro and in vivo studies14,17,23, the trans-
portation of the contrast agent into the cartilage in the intravenous
and intra-articular dGEMRIC methods may be different. At the
moment, there are no in vivo studies comparing the intravenous
and intra-articular dGEMRIC methods in a knee joint of a same
patient.
Contrast-enhanced CT, an analogous X-ray technique to
dGEMRIC, also employs contrast agent (e.g., anionic ioxaglate,
charge 1). There are a range of in vitro studies in which the
contrast-enhanced CT technique has shown its potential in
assessment of GAG content24e28 and biomechanical properties24,29
of cartilage, as well as in detection of cartilage injuries30,31.
Contrast-enhanced CT, referred to as delayed quantitative CT
arthrography (dQCTA) in the present study, has recently been tes-
ted in vivo32, but it has not been thoroughly validated in clinical
settings.
Although the dGEMRIC and contrast-enhanced CT techniques
were initially designed to probe GAG content of the cartilage as well
as degenerative stage of cartilage12,13,25,33e36, they have not been
systematically compared in vivo for the same patients. In the
present study, both dGEMRIC and dQCTAwere conducted in vivo for
patients referred to a knee arthroscopy because of knee pain
symptoms. The hypotheses of the study were: (1) a strong linear
correlation between dGEMRIC and dQCTA parameters should befound, (2) both dGEMRIC and dQCTA parameters should be related
to arthroscopic grading of cartilage, and (3) dGEMRICIV should be
signiﬁcantly related to dGEMRICIA.
Methods
Study subjects
Eleven consecutive patients (eight females and three males)
referred to an arthroscopic surgery of the knee because of persis-
tent knee pain symptoms were enrolled in the present study
(Table I). One patient declined arthroscopy but completed all
imaging studies and one patient was excluded from the analysis
due to irregular distribution of contrast agent in joint. Before
arthroscopy, MRI (three imaging sessions) and CT (two imaging
sessions) examinations were performed as described in Fig. 1.
Informed consent was obtained from all patients. The study was
approved by the Ethical Committee of the Northern Ostrobothnia
Hospital District, Oulu, Finland (No. 33/2010).
MRI
For MRI, each patient was scanned three times on a 3 T scanner
(Siemens Skyra, Siemens Healthcare, Erlangen, Germany) with a
dedicated 15-channel transmit/receive knee coil (Quality Electro-
dynamics (QED), MayField Village, OH, USA). For anatomical
imaging, double echo steady state (DESS) sequence with water
excitation (repetition time (TR)/time to echo (TE) ¼ 14.1/5 ms,
ﬁeld of view (FOV) ¼ 150*150 mm2, matrix ¼ 256*256, slice
thickness ¼ 0.6 mm) was performed in ﬁrst imaging session
whereas T1 relaxation times were measured in all three sessions.
Prior to contrast agent administration, single-slice T1 mapping
was performed at the centre of medial and lateral condyles using
an inversion recovery fast spin echo (IR-FSE) sequence (TR/TE/
inversion time (TI) ¼ 4060/8.6/50, 100, 200, 400, 800, 1600, 3200,
and 3900 ms; FOV ¼ 120*120 mm2; matrix ¼ 256*256; slice
thickness ¼ 3 mm). Subsequently, 0.2 mM/kg (double dose) of
gadopentetate (Gd-DTPA2, Magnevist) was injected intra-
venously, followed by active ﬂexion-extension exercises of the knee
for 5 min and walking for 5 min. T1 measurements were repeated at
90 min after intravenous administration of Gd-DTPA2 using the
same imaging parameters21,33. Two weeks after the previous imag-
ing session, dGEMRICIA was performed after a 20 ml dose of an
ioxaglate e Gd-DTPA2 contrast agent mixture (105 mM Hexabrix
320, Guerbet, Roissy, France and 2.5 mM Magnevist, Bayer
HealthCare Pharmaceuticals, Berlin, Germany; diluted in 0.9% saline;
2 weeks
2-12 weeks
Pre-contrast MRI
Post-contrast MRI at 90 minutes after the
intravenous contrast agent injection (dGEMRICIV)
CT scan at 45 minutes after the
intra-articular contrast agent injection
Post-contrast MRI at 90 minutes after the
intra-articular contrast agent injection (dGEMRICIA)
Intravenous injection of Gd-DTPA2-
CT scan at 5 minutes after the
intra-articular contrast agent injection
Arthroscopy of the knee
Intra-articular injection of the
combination of Gd-DTPA2- and ioxaglate
90 min
5 min
40 min
45 min
Fig. 1. The ﬂow diagram of the study.
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(see CT section below). The post-contrast T1 measurements were
performed at 90 min after intra-articular injection using the
aforementioned imaging protocol.
dGEMRIC analysis
An in-house MATLAB application (v.7.9.0; MathWorks inc.,
Natick,MA,USA)was used to generate T1mapswith a pixel-by-pixel
three-parameter ﬁt routine. Articular cartilage was segmented
manually for thequantitativeT1 analysis. Six regionof interests (ROI)
corresponding to those in arthroscopic evaluation were extracted
from the segmented cartilage, including medial trochlear groove
(MTG) and lateral trochlear groove (LTG) and condyles of tibia and
femur. In addition, a ROI from synovial ﬂuid (SF) was segmented.
First voxel near at the surface of the cartilage as well as at the
cartilageebone interface was excluded from the analyses to avoid
partial volume effect.
The mean T1 relaxation time of each cartilage ROI, i.e., the
dGEMRIC index, was separately calculated for dGEMRICIV and
dGEMRICIA (T1Gd,IV and T1Gd,IA, respectively). Additionally, the
change in relaxation rate was calculated for cartilage and SF (DR1,IV,
DR1,IA, and DR1,SF) as follows33:
DR1 ¼

1=T1Gd  1=T1;0

; (1)
where T1Gd and T1,0 are relaxation time values with and without
Gd-DTPA2, respectively. Furthermore, since the contrast agent is
diluted in the SF after the intra-articular injection, the DR1,IA was
normalized by the DR1,SF (¼DR1,IA/DR1,SF) analogously to the nor-
malized dQCTA parameters.As patella (PAT) was not properly visualized in the dGEMRIC
slices, it was excluded from the analyses. Furthermore, whole car-
tilage surface was not visible in all dGEMRIC slices and thus, the
eventual sample sizes for T1Gd,IV and T1Gd,IA were 53 and 59,
respectively. Sample sizes for DR1,IV, DR1,IA, and DR1,IA/DR1,SF were
50, 54, and 54, respectively.
CT
Before CT scan, the ioxaglate - Gd-DTPA2 contrast agent mix-
ture was injected intra-articularly (see MRI). The contrast agent
mixture was prepared in hospital pharmacy under sterile con-
ditions. Gadopentetate concentration was similar to those typically
used in MR-arthrography37,38. Ioxaglate concentration was lower
than used in CT arthrography39, since hyperosmolaric contrast
agent may cause transient softening of articular cartilage and
negatively affect cartilage if the joint is excessively loaded after
injection40. After injection, the patient performed active ﬂexion-
extension of the knee for 5 min to enable a smooth distribution
of the contrast agent into joint surfaces. After this exercise period,
the knee joint of the patient was scanned using a clinical 64-slice
CT-scanner (Discovery PET/CT 690, GE Medical Systems, Wau-
kesha, WI, USA) with a tube voltage of 100 kV and current of
160 mA. Focal spot size was 0.7 mm and pitch was 0.53. After the
ﬁrst imaging session, the patient was rescanned at 45 min after the
contrast agent injection. The patients avoided walking between CT
imaging sessions. CT scan at 5 min after injection was selected to
correspond with conventional CT arthrography, enabling also the
segmentation of cartilage. It has been suggested that the contrast
agent concentration in cartilage is near to its maximum between 30
and 60 min after injection32, and therefore a 45 min time point for
the second CT scan was selected.
dQCTA analysis
Analyze software (Analyze 10.0, AnalyzeDirect, Inc., Overland
Park, KS, USA) was used in image processing. Since the original
resolution varied between images (232e447 mm), they were
resampled to the same isotropic voxel size (312  312  312 mm3)
using linear interpolation. The segmentation of the cartilage was
conducted using a region growing method. Dimensions of the 3-D
ROI were variable, but they did not exceed the limits that were set
to be one-third of the studied joint surface width. The ROI was
located in the centre of the studied joint surface.
Seven cartilage ROIs were extracted from the same locations as
in the dGEMRIC analyses and, in addition, from the PAT. Fur-
thermore, a SF ROI was selected fromwithin the largest and clearest
SF volume in both CT and MRI. Doubtful voxels were excluded to
avoid partial volume effect.
The mean X-ray attenuation values of the cartilage (C) and SF
ROIs at 5 and 45 min after contrast agent injection (C5, C45, SF5, and
SF45) were calculated to evaluate the contrast agent concentrations.
The contrast agent becomes diluted in SF and the volume of the SF
varies among patients. Therefore, to eliminate any variation in the
equilibrating contrast agent concentration, the cartilage parameters
at each time point were normalized by the contrast agent concen-
tration in the SF at the same time point, i.e., C5/SF5 and C45/SF45.
Since the seed point for the region growing could not be deﬁned
for all cases due to absence of cartilage, the eventual sample size in
dQCTA analyses was 67.
Arthroscopy
After imaging studies, arthroscopy was conducted for the
patients (n ¼ 9) within 2e12 (mean ¼ 5.4, standard deviation
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knee joint (medial condyle of tibia (TMC), medial condyle of femur
(FMC), lateral condyle of tibia (TLC), lateral condyle of femur (FLC),
MTG, LTG, and PAT) were classiﬁed according to the International
Cartilage Repair Society (ICRS) grading system41 by an experienced
orthopaedic surgeon (PL). In the ICRS grading scale, intact cartilage
is graded as 0, slightly softened indentation stiffness and/or
superﬁcial ﬁssures and cracks as 1, lesions extending less than 50%
of cartilage depth as 2, cartilage lesions extending 50% or more of
cartilage depth but not into the subchondral bone as 3, and carti-
lage lesions extending into the subchondral bone as 4. ICRS grading
was missing from four sites and thus, the total number of ICRS
graded sites was 59.
Statistical analysis
Statistical analyses were performed using SPSS 19 software
(SPSS Inc., Chicago, IL, USA). The level of statistical signiﬁcance was
set to P < 0.05. Normal distribution of the parameters was tested
using KolmogoroveSmirnov test and based on the normality of the
parameters either Pearson (r) or Spearman (rs) correlation analysis
(together with 95% conﬁdence intervals [CI])42 was applied. Dif-
ferences between the correlation coefﬁcients were statistically
compared by using Fisher’s transform43. KruskaleWallis test was
used for group comparisons.
Results
The mean T1 relaxation time values in the cartilage were 59%
(range among the different anatomical sites: 46e68%) and 45%
(34e50%) lower after intravenous and intra-articular contrast agent
injection than without contrast agent, respectively, whereas the SF
relaxation time values were 90% and 67% lower, respectively
(Table II). DR1 values in the cartilage were 76% (44e124%) higher
after intravenous injection than after intra-articular injection
(Table II).
The mean X-ray attenuation in the cartilage was 27% (22e38%)
higher whereas the attenuation in the SF was 62% lower at
45 min than at 5 min after contrast agent injection (Table II). The
mean C45/SF45 value was 222% (209e254%) higher than the mean
C5/SF5 value (Table II).
Comparison of dGEMRIC and dQCTA
Representative MR and CT images, T1 relaxation time map
overlaid on top of an MR image, and illustrative dQCTA map of C45/
SF45 overlaid on top of a CT image of a patient with ICRS grade 2
cartilage lesion are presented in Fig. 2. In quantitative analyses,Table II
The mean (SD) X-ray attenuation values (Hounsﬁeld Units) and normalized dQCTA p
relaxation time (ms) and DR1 (1/s) values in SF and in cartilage. The mean X-ray attenuati
The mean attenuation was lower in the SF at 45 min after injection that at 5 min after inj
after intravenous and intra-articular contrast agent administration than without contras
CT at 5 min CT at 45 min C5/SF5 C45/SF45 T1
SF 1168  294 439  80 e e 3
PAT 184  38 228  53 0.17  0.05 0.53  0.15 e
LTG 154  18 194  28 0.14  0.04 0.46  0.07 1
MTG 164  32 211  46 0.16  0.05 0.49  0.12 1
FLC 136  16 187  26 0.12  0.03 0.44  0.09 1
FMC 198  47 253  55 0.19  0.08 0.59  0.16 1
TLC 147  49 183  66 0.14  0.06 0.43  0.19 1
TMC 213  69 260  74 0.19  0.06 0.60  0.18 1
Cx ¼ cartilage, x ¼ time in minutes from contrast agent injection, T1,0 ¼ T1 relaxation time
articularly administered contrast agent.
* T1 relaxation time in SF could not be deﬁned for two patients.dGEMRICIV correlated strongest with normalized dQCTA parame-
ters (Table III, Fig. 3), while dGEMRICIA correlated strongest with
dQCTA at 45 min after the both parameters were normalized with
contrast agent concentration in SF (Table III).
When studying relation between dGEMRIC and dQCTA in intact
and slightly degraded cartilage (ICRS ¼ 0e1), DR1,IV and DR1,IA/
DR1,SF correlated with C45/SF45 (r ¼ 0.65 [0.36e0.82], n ¼ 28,
P < 0.01 and rs ¼ 0.81 [0.63e0.91], n ¼ 29, P < 0.01, respectively).
These correlations were not signiﬁcantly different from those in the
whole population (ICRS ¼ 0e3).
Association of arthroscopy to dGEMRIC and dQCTA
In the arthroscopy, ICRS classiﬁcation for the predetermined
cartilage surfaces varied from normal (grade 0, n ¼ 19) and nearly
normal (grade 1, n ¼ 19) to abnormal (grade 2, n ¼ 19) and severely
abnormal (grade 3, n ¼ 2).
dQCTA showed a trend towards increasing values with severity
of cartilage damage seen in arthroscopy. However, dQCTA and
dGEMRIC parameters were not statistically signiﬁcantly different in
different ICRS grade groups (Fig. 4).
Association of dGEMRICIV and dGEMRICIA
There was no association between dGEMRICIV and dGEMRICIA
when correlating either T1 relaxation time values (r ¼ 0.12
[0.38e0.16], n ¼ 53, P ¼ 0.39) or DR1 values (rs ¼ 0.01 [0.29e
0.27], n¼ 50, P¼ 0.95). When DR1,IA was normalized by the DR1,SF, a
signiﬁcant correlation to DR1,IV was established (rs ¼ 0.52 [0.28e
0.70], n ¼ 50, P < 0.01).
Discussion
In the present study, we hypothesized that there is a strong
relationship between the dGEMRIC and dQCTA techniques due to
the similar methodological approach used with these two different
modalities. This hypothesis was conﬁrmed, yet, the relation was
dependent on whether the parameters were normalized with
contrast agent concentration in SF or not. Second, we hypothesized
that dGEMRIC and dQCTA would be related to arthroscopic ICRS
grading of cartilage. However, this association was not observed.
Third, we hypothesized that there is a relationship between
dGEMRICIV and dGEMRICIA. The relationship between these two
dGEMRIC methods was signiﬁcant only when the DR1,IA was nor-
malized by the DR1 in SF.
The correlation between dGEMRIC and dQCTA was expected,
since both of these methods are based on the use of the anionic
contrast agent and proposed for the quantiﬁcation of the cartilagearameters at 5 and 45 min after contrast agent injection, and the mean (SD) T1
on in the cartilage was higher at 45 min after injection than at 5 min after injection.
ection. The mean T1 relaxation time values in the cartilage and in the SF were lower
t agent
,0 T1Gd,IV T1Gd,IA DR1,IV DR1,IA
427  367 345  30* 1122  385 e 0.71  0.38
e e e e
337  121 536  63 742  118 1.14  0.28 0.62  0.18
441  250 550  98 748  115 1.02  0.25 0.70  0.20
402  303 535  51 741  146 1.14  0.28 0.65  0.17
493  174 484  122 752  149 1.54  0.61 0.69  0.19
077  122 578  102 711  67 0.85  0.36 0.48  0.08
041  203 484  93 584  94 1.27  0.57 0.79  0.24
without contrast agent, IV ¼ intravenously administered contrast agent, IA ¼ intra-
Fig. 2. Sagittal MR (AeC) and CT (DeF) images from the corresponding location in a patient with ICRS grade 2 cartilage lesion (arrow). According to visual evaluation, CT conducted
at 5 min after the contrast agent injection had the best diagnostic quality for evaluation of cartilage lesions. (A) Anatomical DESS image (TE/TR ¼ 5/14.1 ms) prior to contrast agent
administration. (B) IR-FSE image (TI/TE/TR ¼ 200/8.6/4060 ms) prior to contrast agent administration (note: cartilage appears thinner as compared to DESS due to longer TR). (C) T1
relaxation time map of cartilage overlaid on top of a T1-weighted MR image after intravenous contrast agent administration. (D) CT at 5 min and (E) CT at 45 min after contrast agent
injection. (F) Illustrative dQCTA map of normalized X-ray attenuation in cartilage at 45 min after contrast agent injection (C45/SF45) overlaid on top of an anatomical CT image.
Contrast of the images has been adjusted to enhance visibility of the lesion.
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niﬁcantly depending on which parameters were used to quantify
the contrast agent concentration in cartilage. The strongest corre-
lations between dGEMRICIV and dQCTA were obtained when
dQCTA parameters were normalized with the contrast agent con-
centration in SF. Further, strongest correlation between dGEMRICIA
and normalized dQCTA was established when dGEMRICIA was
normalized by the DR1 in SF. These ﬁndings underline the impor-
tance to consider the contrast agent concentration in SF in dGEM-
RICIA and dQCTA analyses, particularly in patient populations with
expected differences in SF volume. dQCTA and dGEMRIC were
similarly related even after excluding severe degenerative cases
(ICRS ¼ 2e3) from the analyses. This result suggests that these two
techniques share similar features also when only intact or slightly
degenerated cartilage is investigated. Pharmacokinetically, dGEM-
RIC at 90 min is closest to the dQCTA at 45 min, yet the authors
acknowledge the considerable difference in time between these
two measurements. However, the selection of imaging time points
was based on the literature21,32,33. It is likely that at 5 min after
intra-articular injection, the contrast agent was poorly diffused into
cartilage and thus, the correlations with dGEMRIC parameters were
lower. Differences in pharmacokinetics between intra-articular and
intravenous administration and between the applied contrast
agentsmay explain some of the variation in correlations. It has beenTable III
Spearman rank correlation coefﬁcients (95% CI) between dGEMRIC and dQCTA paramete
with contrast agent concentration in SF and DR1,IA was normalized with change in relax
C5 C45
DR1,IV 0.28 (0.01e0.52) 0.39 (0.12e0.60)**
DR1,IA 0.42 (0.16e0.62)** 0.42 (0.17e0.62)**
DR1,IA/DR1,SF 0.10 (0.18e0.36) 0.16 (0.12e0.42)
T1Gd,IV 0.31 (0.54 to 0.04)* 0.42 (0.62 to 0.1
T1Gd,IA 0.43 (0.62 to 0.18)** 0.42 (0.61 to 0.1
*P < 0.05, **P < 0.01.
Cx ¼ cartilage, x ¼ time in minutes from contrast agent injection.
IV ¼ intravenously administered contrast agent.
IA ¼ intra-articularly administered contrast agent.proposed that the transportation of the contrast agent into the
cartilage in intravenous and intra-articular injection may be dif-
ferent13, although the diffusion from the subchondral bone
was negligible in recent studies14,17,23. Furthermore, it was pre-
viously shown that the penetration of gadopentetate and ioxaglate
into cartilage is different due to their different molecular masses
and charges (gadopentetate: 548 g/mol, 2; ioxaglate: 1269 g/
mol, 1)14,44. The mean attenuation in the SF decreased by 62%
between the 5 and 45 min time points parallel with the results in a
previous study with two patients CT scanned before and at 30, 60,
and 120 min after intra-articular injection of 50% ioxaglate sol-
ution32. It should be noted that a high correlation (rs ¼ 0.91,
P< 0.01) was observed between DR1,SF and SF45, indicating that the
initial equilibrating conditions for dQCTA and dGEMRICIA were
similar.
Neither dQCTA nor dGEMRIC parameters were signiﬁcantly
different between different ICRS grades. Thus the hypothesis that
both quantitative dQCTA and dGEMRIC are related to arthroscopic
ICRS grading, could not be conﬁrmed. This ﬁnding is in agreement
with two previous studies in which the dGEMRIC parameters did
not correlate with the arthroscopic ﬁndings35,45. Owman et al.
(2008) calculated the dGEMRIC index for the TLC, FLC and TMC,
FMC35 whereas Nojiri et al. (2006) calculated it only for the lesion in
the PAT45. However, those and the present results contradict withrs. Strongest correlations were observed when dQCTA parameters were normalized
ation rate in SF
C5/SF5 C45/SF45
0.42 (0.16e0.63)** 0.72 (0.56e0.83)**
0.27 (0.01e0.50) 0.06 (0.22e0.32)
0.13 (0.15e0.39) 0.70 (0.53e0.82)**
6)** 0.48 (0.66 to 0.23)** 0.68 (0.80 to 0.50)**
8)** 0.26 (0.49e0.01) 0.03 (0.24e0.29)
Fig. 3. Statistically signiﬁcant positive correlation between normalized mean attenu-
ation in cartilage at 45 min after contrast agent injection (C45/SF45) and DR1,IV was
observed. Linear ﬁt is for illustrative purposes.
J. Hirvasniemi et al. / Osteoarthritis and Cartilage 21 (2013) 434e442 439another study that reported signiﬁcantly different R1 and DR1 val-
ues between the OA and reference compartments33. This may be
due to the fact that Tiderius et al. (2003) limited their analysis to
the load bearing FLC and FMC, representing a more homogenous
selection of cartilage. All those three studies were conducted at
1.5 T MRI at 90e120 min after intravenous injection of Gd-DTPA2
(0.1e0.3 mM/kg)33,35,45. The present study consisted of ROIs at
various locations, and cartilage properties including the dGEMRIC
index have previously been shown to vary across different cartilage
surfaces46,47. Further, the remaining cartilage is analysed in the
quantitative dGEMRIC and dQCTA analyses, whereas in arthroscopy
the absence of cartilage deﬁnes the classiﬁcation. Hence, when
there is an observed cartilage lesion in the arthroscopy, the quality
of the underlying cartilage is actually evaluated with the dGEMRIC
and dQCTA techniques. However, the remaining cartilage layer
just under the lesion should likely have also at least someFig. 4. Comparison of dQCTA (A: C5/SF5 and B: C45/SF45) and dGEMRIC (C: DR1,IV and D: DR
different ICRS grade groups were not signiﬁcant. ICRS grades 2 and 3 were merged into ondegenerative changes. Furthermore, the cartilage analysed in the
dGEMRIC or dQCTA may not cover the whole lesion evaluated in
arthroscopy. Theoretically, the dGEMRIC and contrast-enhanced
CT methods may detect changes in the cartilage earlier than they
are manifested in the arthroscopy. This may allow earlier inter-
vention in disease process with an appropriate approach and these
imaging methods may also help to develop new disease-modifying
drugs for OA by enabling more accurate and minimally invasive
(compared to arthroscopy) follow-up of cartilage changes. How-
ever, to conﬁrm those hypotheses, further studies are required.
When comparing dGEMRICIV and dGEMRICIA parameters, we
found a moderate correlation only between DR1,IA/DR1,SF and DR1,IV.
Correlation between the dGEMRIC indices or between the non-
normalized DR1,IA and DR1,IV was not signiﬁcant. Several reasons
can be suggested to explain this ﬁnding. First, the intra-articular
contrast agent concentration will be diluted by the SF, and the SF
volume may vary among patients, as discussed above. Second, the
volume of contrast agent for intra-articular administration was
constant for all patients while the volume for intravenous admin-
istration depended on the weight of the patient. Third, as discussed
earlier, contrast agent diffusion into cartilage may not be similar in
intravenous and intra-articular injection, although the diffusion
from the subchondral bone was found to be negligible in a recent
in vivo study with healthy volunteers scanned at 1.5 T MRI before
and at 12e240 min after intravenous injection of Gd-DTPA2
(0.3 mM/kg)23. Fourth, the time delays between the post-contrast
imaging, yet similar for intra-articular and intravenous admin-
istration in this study, may further inﬂuence the accumulation of
contrast agent into cartilage13. On average, the relaxation time
values were 26% lower and DR1 values were 76% higher in the
intravenous injection than in the intra-articular injection, indicat-
ing that contrast agent concentration in the cartilage was higher
after intravenous injection. The optimal delay for intra-articular
imaging has not been sufﬁciently investigated and requires fur-
ther investigation. In the knee, the typical time delay between
intravenous injection and imaging has been 90e180 min21,33,48. In1,IA/DR1,SF) parameters between different ICRS grade groups. Differences between the
e group due to low number of lesions with grade 3.
J. Hirvasniemi et al. / Osteoarthritis and Cartilage 21 (2013) 434e442440the study of Bashir et al. (1997) intra-articular contrast agent was
combined with epinephrine to slow down the extraction of the
contrast agent and imaging was performed 2.5e7 h after intra-
articular injection of the contrast agent. In the present study, epi-
nephrine was not used.
This study contains limitations that need to be addressed. First,
the time delay between contrast agent injection and imaging was
not identical in dGEMRICIA and dQCTA, since we chose to inject
both MR and CT contrast agents at the same time for ethical rea-
sons. Second, intra-articular injection is more challenging to con-
duct than intravenous injection, which was also observed in the
present study. Due to anatomical variations between patients,
contrast agent did not distribute uniformly into joint surfaces in
one intra-articular injection. This injection was given to supra-
patellar recess of the knee, which is the most common injection
site to knee joint49. There is generally awide communicationwithin
the knee joint, but rarely, this pouch can remain isolated and
independent of the synovial cavity. The remaining injections were
given straight to the knee joint. This is recommended to keep the
intra-articular concentration of the contrast agent stable. Third,
segmentation procedures were different in dGEMRIC and dQCTA,
however, the agreement of segmentation was conﬁrmed visually.
Unlike for MRI, automated segmentation in dQCTA was performed
since this can be more easily conducted due to the higher contrast
between cartilage and adjacent tissues. As compared to CT, image
acquisition takes longer time in dGEMRIC and imaging single slices
per condyle in dGEMRICmade the imaging time reasonable. Fourth,
the dQCTA and dGEMRIC analyses were not directly co-registered,
and consequently the cartilages between different modalities may
not fully correspond to each other. Although the analyses were not
directly co-registered, theywere still very closelymatched by visual
evaluation and by selecting similar slice orientation in CT as in
dGEMRIC. Finally, as discussed earlier, the dGEMRIC index for car-
tilage varies across and within joint surfaces46,47. Perceiving this
fact, we did not calculate site-speciﬁc correlations between
dGEMRIC or dQCTA parameters and ICRS grading due to limited
sample size. This confounds the interpretation of the present
results.
This study suggests that the dQCTA is in best agreement with
dGEMRICIV at 45 min after ioxaglate injection. However, if judged
only with visual evaluation by the experienced radiologist (RO), the
CT conducted at 5 min after the injection had the best diagnostic
quality for evaluation of cartilage lesions. Thus, two separate scans
might offer the optimal result for both qualitative and quantitative
evaluation of cartilage. However, both logistics and radiation
exposure may hinder the application of two separate scans,
although low radiation dose procedures for the imaging of the knee
joint have been introduced50. Thus, further studies are still needed
to optimize the imaging delay for dQCTA.
In conclusion, normalized dQCTA at 45 min time point was
related to dGEMRICIV and to normalized dGEMRICIA parameters.
dQCTA and dGEMRIC were not related to arthroscopic grading,
probably because the remaining cartilage is analysed in the
dGEMRIC and dQCTA analyses, whereas in arthroscopy the absence
of cartilage deﬁnes the classiﬁcation. dGEMRICIV and dGEMRICIA
were related after change in relaxation rate in SF was taken into
account in dGEMRICIA analyses. The ﬁndings of the study indicate
the importance to take into account the contrast agent concen-
tration in SF in dQCTA and dGEMRICIA.Author contributions
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